Hemagen Diagnostics Inc HMGN

$0.00 0.00 (—)

Valuation

Market cap
0
Revenue TTM
$4,040,000
Net income TTM
$-910,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-22.52%
Debt to equity
0.00

Trading

Volume
19,700
Avg volume
—
Day's range
$0.00 – $0.00
Shares out
—
Stochastic %K
0%
Beta
20.54
Analysts
—
Price target
—

Price

Company profile

Hemagen Diagnostics, Inc. provides human and veterinary diagnostic services worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its proprietary test kits are used to aid in the diagnosis of certain autoimmune and infectious diseases. It also provides human diagnostics, such...

Show more

Hemagen Diagnostics, Inc. provides human and veterinary diagnostic services worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its proprietary test kits are used to aid in the diagnosis of certain autoimmune and infectious diseases. It also provides human diagnostics, such as universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company offers veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. Its products are used in laboratories, hospitals and blood banks. Hemagen Diagnostics, Inc. was incorporated in 1985 and is based in Columbia, Maryland.

Industry
Biotechnology
Sector
Healthcare
Phone
443-367-5500
Website
https://www.hemagen.com
Address
9033 Red Branch Road, Columbia, United States

Latest news

No headlines yet.